$594 Million is the total value of VR Adviser, LLC's 28 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLDX | Exit | Celldex Therapeutics Inc | $0 | – | -75,000 | -100.0% | -0.32% | – |
| IMCR | Exit | Immunocore Holdings PLCads | $0 | – | -94,605 | -100.0% | -0.68% | – |
| ALT | Exit | Altimmune Inc | $0 | – | -369,306 | -100.0% | -0.73% | – |
| RXDX | Exit | Prometheus Biosciences Inc | $0 | – | -121,663 | -100.0% | -1.11% | – |
| Exit | Ventyx Biosciences Inc | $0 | – | -207,925 | -100.0% | -1.12% | – | |
| AKUS | Exit | Akouos Inc | $0 | – | -2,800,566 | -100.0% | -2.92% | – |
| TIL | Exit | Instil Bio Inc | $0 | – | -4,105,779 | -100.0% | -3.07% | – |
| GOSS | Exit | Gossamer Bio Inc | $0 | – | -1,747,000 | -100.0% | -3.23% | – |
| RLMD | Exit | Relmada Therapeutics Inc | $0 | – | -1,518,056 | -100.0% | -8.67% | – |
| TCDA | Exit | Tricida Inc | $0 | – | -9,050,064 | -100.0% | -14.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.